SLShuangming Lin

Shuangming Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shuangming Lin has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Dongbo Xu

    Department of Gastrointestinal Surgery, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China

    8 shared publications
  • Hao Zeng

    Department of Gastroenterology and Anorectal Surgery, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China

    8 shared publications
  • Xueyi Xue

    Department of Gastroenterology and Anorectal Surgery, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China

    8 shared publications
  • Baofeng Liang

    Department of Gastroenterology and Anorectal Surgery, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China

    6 shared publications
  • Xiaojie Wang

    Department of Colorectal Surgery Fujian Medical University Union Hospital Fujian Province China

    6 shared publications
  • Dongbo Chen

    Longyan Digestive Diseases Research Center Longyan Fujian Province China

    5 shared publications

Latest Publications

  • Threshold association analysis between residual tumour size and distant metastasis risk after neoadjuvant therapy for rectal cancer: A multicentre retrospective study

    by Hao Zeng, Xueyi Xue, Dongbo Chen, Xiaojie Wang, Kun Lan, Zhilong Yuan, Wenchang Gan, Baodong Liao, Bozhang Wu, Dongbo Xu, et al.

    Purpose: This study aimed to perform a threshold analysis of residual tumour size (RTS) to identify the critical threshold influencing distant metastasis (DM), thereby enabling more precise risk stratification. Methods: This multicentre retrospective cohort study included patients with locally advanced rectal cancer who underwent radical surgery following neoadjuvant chemoradiotherapy (nCRT). Kaplan–Meier survival curves were plotted and compared using the log‐rank test. Multivariable Cox proportional hazards models were used to identify independent prognostic factors. The threshold‐effect analysis was performed to determine the potential critical point of RTS. Results: In this multi‐institutional study, threshold‐effect analysis identified a significant inflection point at 3 cm for the association between RTS and DM risk. Below this threshold, each 1‐cm increase was associated with a markedly higher risk (HR = 1.70, p = 0.015), whereas no significant association was observed above 3 cm ( p = 0.692). Patients with an RTS ≥3 cm exhibited significantly poorer early (≤ 24 months) recurrence‐free survival (RFS) and disease‐free survival (DFS). After 24 months, the pattern was reversed. RTS ≥3 cm was an independent risk factor for both worse RFS (HR = 1.45, p = 0.033) and DM. Subgroup analyses confirmed the consistent negative prognostic impact of RTS ≥3 cm across most strata. Conclusions: This study established an objective prognostic threshold for RTS following nCRT. This marks a shift in the understanding of this indicator—from a static association between ‘risk and size’ to a dynamic association between ‘risk and time’.

  • Comparison of different surgical techniques and anastomosis methods in short-term outcomes of right colon cancer: a network meta-analysis of open surgery, laparoscopic, and robot-assisted techniques with extracorporeal and intracorporeal anastomosis

    by Baodong Liao, Xueyi Xue, Hao Zeng, Wen Ye, Tingjiang Xie, Xiaojie Wang, Shuangming Lin

    With the rapid development of minimally invasive surgical techniques, there remains considerable controversy regarding the choice of surgical approach and anastomosis method for patients with right-sded colon cancer (RSCC). This meta-analysis compared the short-term outcomes of open right colectomies (ORC), laparoscopic right colectomies with intracorporeal and extracorporeal anastomosis (LRC-IA and LRC-EA), as well as robot right colectomies with intracorporeal and extracorporeal anastomosis (RRC-IA and RRC-EA). A systematic search was conducted across PubMed (n = 549), Web of Science (n = 821), Embase (n = 591), and the Cochrane Central Register (n = 86) from January 2000 to August 2024. Studies comparing at least two of the surgical techniques for RSCC were included. The primary outcomes evaluated were overall complications, wound infection, ileus, and reoperation rates. Secondary outcomes included operative time, blood loss, hospital stay, time to resume diet, and conversion rates. A Bayesian network meta-analysis was performed. A total of 39 studies comprising 6098 patients were included. The results indicated that LRC-IA had the lowest overall complication rate (OR 0.65; 95% CI [0.41, 1.07]), while ORC had the highest. RRC-IA was most effective in reducing wound infection (OR 0.77; 95% CI [0.39, 1.35]), blood loss (MD 18.01; 95% CI [4.62, 40.87]), and hospital stay (MD 0.93; 95% CI [0.67, 1.31]), while also demonstrating advantages in preventing postoperative ileus (OR 0.47; 95% CI [0.05, 1.31]) and ensuring faster bowel function recovery (OR 0.80; 95% CI [0.44, 1.53]). The analysis demonstrates that for patients with RSCC, RRC shows better short-term outcomes compared to LRC and ORC, while IA also surpasses EA.


  • Open Access

    Improved lymph node detection in minimally invasive radical surgery for colorectal cancer using nanocarbon tracer

    by Bingkai Xie, Guihe Lin, Zhijian Wang, Dongbo Xu, Jianxun Chen, Shuangming Lin

    To investigate the influencing factors of lymph node detection after minimally invasive radical surgery in patients with colorectal cancer (CRC) and the application value of carbon nanoparticle tracing. A total of 120 patients with CRC who underwent minimally invasive radical surgery were included. They were divided into groups according to whether they were grouped by carbon nano-tracers, and the baseline data were matched by propensity score method. Univariate and multivariate methods were used to evaluate lymph nodes and positive lymph nodes after minimally invasive radical surgery. The number of detected independent factors. After propensity score matching, there were 37 patients in the tracer group and the non-tracer group; there was no significant difference in baseline data between the two groups; the number of positive lymph nodes detected in the tracer group was significantly higher than that in the non-tracer group. The results of univariate analysis showed that gender, lesion location, maximum tumor diameter, and whether to perform nanocarbon tracing were all related to the number of lymph nodes detected after minimally invasive radical surgery. Nanocarbon tracing was an independent influencing factor for the number of lymph nodes detected after minimally invasive radical surgery. Pathological type, T stage, histopathological grade, nerve invasion, and whether or not with cancer nodules were all related to the number of positive lymph nodes detected after minimally invasive radical surgery; multivariate analysis showed that T stage, pathological Histological grade, vascular invasion, and cancer nodules were all independent influencing factors for the number of positive lymph nodes detected after minimally invasive radical surgery. The number of lymph nodes detected in patients with CRC after minimally invasive radical surgery is closely related to the location of the lesion and whether carbon nanoparticle tracing is performed; those with T2-4 stage, histological grade 3–4, combined with vascular invasion and cancer nodules are more likely to Positive lymph nodes were detected.


  • Open Access

    Impact of lymph node retrieval on prognosis in elderly and non-elderly patients with T3-4/N+ rectal cancer following neoadjuvant therapy: a retrospective cohort study

    by Baofeng Liang, Sisi Xie, Nong Yu, Xueyi Xue, Hao Zeng, Zhipeng Que, Dongbo Xu, Xiaojie Wang, Shuangming Lin

    Purpose: The optimal number of lymph nodes to be resected in patients with rectal cancer who undergo radical surgery after neoadjuvant therapy remains controversial. This study evaluated the prognostic variances between elderly and non-elderly patients and determined the ideal number of lymph nodes to be removed in these patients. Methods: The Surveillance, Epidemiology, and End Results (SEER) datasets were used to gather information on 7894 patients diagnosed with stage T3-4/N+ rectal cancer who underwent neoadjuvant therapy from 2010 to 2019. Of these patients, 2787 were elderly and 5107 were non-elderly. A total of 152 patients from the Longyan First Affiliated Hospital of Fujian Medical University were used for external validation. Overall survival (OS) and cancer-specific survival (CSS) were evaluated to determine the optimal quantity of lymph nodes for surgical resection. Results: The study found significant differences in OS and CSS between elderly and non-elderly patients, both before and after adjustment for confounders (P < 0.001). The removal of 14 lymph nodes may be considered a benchmark for patients with stage T3-4/N+ rectal cancer who undergo radical surgery following neoadjuvant therapy, as this number provides a more accurate foundation for the personalized treatment of rectal cancer. External data validated the differences in OS and CSS and supported the 14 lymph nodes as a new benchmark in these patients. Conclusion: For patients with T3-4/N+ stage rectal cancer who undergo radical surgery following neoadjuvant therapy, the removal of 14 lymph nodes serves as a cutoff point that distinctly separates patients with a favorable prognosis from those with an unfavorable one.


  • Open Access

    Predicting treatment failure in stage III colon cancer patients after radical surgery

    by Hao Zeng, Xuejing Zhong, Wenxin Liu, Baofeng Liang, Xueyi Xue, Nong Yu, Dongbo Xu, Xiaojie Wang, Shuangming Lin

    Purpose: The aim to assess treatment failure in patients with stage III colon cancer who underwent radical surgery and was analyzed using the nomogram.Methods: Clinical factors and survival outcomes for stage III colon cancer patients registered in the SEER database from 2018 to 2019 were analyzed, with patients split into training and testing cohorts (7:3 ratio). A total of 360 patients from the First Affiliated Hospital of Longyan served as an external validation cohort. Independent predictors of treatment failure were identified using logistic regression analyses. The nomograms was evaluated by concordance index (C-index), calibration curves, and the area under the curve (AUC), decision curve analysis (DCA) and clinical impact curves (CIC) assessed the clinical utility of nomograms versus TNM staging.Results: The study included 4,115 patients with stage III colon cancer. Multivariate logistic analysis age, tumor site, pT stage, pN stage, chemotherapy, pretreatment CEA levels, number of harvested lymph nodes, perineural invasion and marital status were identified as independent risk factors for treatment failure. The C-indices for the training and testing sets were 0.853 and 0.841. Validation by ROC and calibration curves confirmed the stability and reliability of the model. DCA showed that the net clinical effect of the histogram was superior to that of the TNM staging system, while CIC highlighted the potentially large clinical impact of the model.Conclusions: The developed Nomogram provides a powerful and accurate tool for clinicians to assess the risk of treatment failure after radical surgery in patients with stage III colon cancer.


  • Open Access

    Conditional survival analysis and real-time prognosis prediction in stage III T3–T4 colon cancer patients after surgical resection: a SEER database analysis

    by Hao Zeng, Xueyi Xue, Dongbo Chen, Biaohui Zheng, Baofeng Liang, Zhipeng Que, Dongbo Xu, Xiaojie Wang, Shuangming Lin

    Background: Conditional survival (CS) takes into consideration the duration of survival post-surgery and can provide valuable additional insights. The aim of this study was to investigate the risk factors associated with reduced one-year postoperative conditional survival in patients diagnosed with stage III T3–T4 colon cancer and real-time prognosis prediction. Furthermore, we aim to develop pertinent nomograms and predictive models. Methods: Clinical data and survival outcomes of patients diagnosed with stage III T3–T4 colon cancer were obtained from the Surveillance, Epidemiology, and End Results (SEER) database, covering the period from 2010 to 2019. Patients were divided into training and validation cohorts at a ratio of 7:3. The training set consisted of a total of 11,386 patients for conditional overall survival (cOS) and 11,800 patients for conditional cancer-specific survival (cCSS), while the validation set comprised 4876 patients for cOS and 5055 patients for cCSS. Univariate and multivariate Cox regression analyses were employed to identify independent risk factors influencing one-year postoperative cOS and cCSS. Subsequently, predictive nomograms for cOS and cCSS at 2-year, 3-year, 4-year, and 5-year intervals were constructed based on the identified prognostic factors. The performance of these nomograms was rigorously assessed through metrics including the concordance index (C-index), calibration curves, and the area under curve (AUC) derived from the receiver operating characteristic (ROC) analysis. Clinical utility was further evaluated using decision curve analysis (DCA). Results: A total of 18,190 patients diagnosed with stage III T3–T4 colon cancer were included in this study. Independent risk factors for one-year postoperative cOS and cCSS included age, pT stage, pN stage, pretreatment carcinoembryonic antigen (CEA) levels, receipt of chemotherapy, perineural invasion (PNI), presence of tumor deposits, the number of harvested lymph nodes, and marital status. Sex and tumor site were significantly associated with one-year postoperative cOS, while radiation therapy was notably associated with one-year postoperative cCSS. In the training cohort, the developed nomogram demonstrated a C-index of 0.701 (95% CI, 0.711–0.691) for predicting one-year postoperative cOS and 0.701 (95% CI, 0.713–0.689) for one-year postoperative cCSS. Following validation, the C-index remained robust at 0.707 (95% CI, 0.721–0.693) for one-year postoperative cOS and 0.700 (95% CI, 0.716–0.684) for one-year postoperative cCSS. ROC and calibration curves provided evidence of the model's stability and reliability. Furthermore, DCA underscored the nomogram’s superior clinical utility. Conclusions: Our study developed nomograms and predictive models for postoperative stage III survival in T3–T4 colon cancer with the aim of accurately estimating conditional survival. Survival bias in our analyses may lead to overestimation of survival outcomes, which may limit the applicability of our findings.


  • Comparing the short-term clinical outcomes and therapeutic effects of different colectomies in patients with refractory slow-transit constipation in eastern countries: a network meta-analysis

    by Xueyi Xue, Hao Zeng, Dongbo Chen, Biaohui Zheng, Baofeng Liang, Dongbo Xu, Shuangming Lin

    Surgical treatment has been widely used in patients with refractory slow transit constipation (RSTC). The aim of this network meta-analysis (NMA) was to compare the effects of different colectomies on short-term postoperative complications and quality of life in patients with RSTC. Electronic literature searches were performed in the PubMed, Web of Science, EMBASE, WANFANG DATA, and Cochrane Central Register of controlled trials databases and were searched up to December 2022. Selected to compare the short-term clinical outcomes and quality of life of the treatment of RSTC. A random-effects Bayesian NMA was conducted to assess and rank the effectiveness of different surgical modalities. This study included a total of six non-randomized controlled trials involving 336 subjects. It was found that subtotal colectomy with cecorectal anastomosis (CRA) demonstrated superior effectiveness in several aspects, including reduced hospital stay (MD 0.06; 95% CI [0.02, 1.96]), shorter operative time (MD 4.75; 95% CI [0.28, 14.07]), lower constipation index (MD 0.61; 95% CI [0.04, 1.71]), improved quality of life (MD 4.42; 95% CI [0.48, 4.42]). Additionally, in terms of short-term clinical outcomes, subtotal colectomy with ileosigmoidal anastomosis (SC-ISA) procedure ranked the highest in reducing small bowel obstruction (OR 0.24; 95% CI [0.02, 0.49]), alleviating abdominal pain (OR 0.53; 95% CI [0.05, 1.14]), minimizing abdominal distension (OR 0.33; 95% CI [0.02, 0.65]), and reducing incision infection rates (OR 0.17; 95% CI [0.01, 0.33]). Furthermore, SC-ISA ranked as the best approach in terms of patient satisfaction (OR 0.66; 95% CI [0.02, 1.46]). Based on our research findings, we recommend that CRA be considered as the preferred treatment approach for patients diagnosed with RSTC.


  • Open Access

    Reduced recurrence rates with partial resection for stage III T1-2 colon cancer compared to hemicolectomy resection: a SEER database analysis

    by Hao Zeng, Dongbo Chen, Xueyi Xue, Biaohui Zheng, Baofeng Liang, Xuejing Zhong, Pang Zou, Dongbo Xu, Xiaojie Wang, Shuangming Lin

    Purpose The aim of our study was to compare the oncological survival outcomes between partial colectomy (PC) and hemicolectomy (HC) in patients diagnosed with stage III T1-2 colon cancer. Methods A total of 4,248 patients diagnosed with stage III T1-2 colon cancer, who underwent either hemicolectomy (n = 2,348) or partial colectomy (n = 1,900) between 2010 and 2019, were included in the Surveillance, Epidemiology, and End Results (SEER) database. We conducted a comparative analysis of overall survival (OS) and cancer-specific survival (CSS) between these two surgical groups. Additionally, we sought to determine the optimal thresholds for the number of harvested lymph nodes and tumor size. Predictive nomograms for patients with Stage III T1-2 colon cancer were constructed using independent risk factors identified CSS. Results The results revealed significant differences between the PC and HC groups in terms of age, gender, race, tumor site, histopathology, stage, pT, pN, scope of regional lymph nodes, postoperative chemotherapy, postoperative radiation, harvested lymph nodes, CEA pretreatment, marital status, and tumor size (all with P < 0.05). It was observed that hemicolectomy patients had slightly lower OS and CSS rates than patients who underwent partial colectomy (all with P < 0.001). Following propensity score matching (PSM), the OS and CSS rates in the two groups remained significantly different (P < 0.05). The survminer R package was employed to determine the optimal thresholds for harvested lymph node and tumor size counts in stage III T1-2 colon cancer patients, which were found to be 10 and 4.7 cm, respectively. Notably, CSS did not significantly differ between patients with ≥ 10 lymph nodes harvested and those with ≥ 12 lymph nodes harvested (P = 0.72). Univariate and multivariate Cox regression analyses, as well as survival analyses of stage III T1-2 colon cancer patients, demonstrated that patients receiving partial colectomy experienced a superior survival benefit compared to those undergoing hemicolectomy. Conclusions In the treatment of stage III T1-2 colon cancer patients, partial colectomy demonstrates significant oncological advantages over hemicolectomy. Harvested a minimum of 10 lymph nodes is more effective than the conventional threshold of 12 lymph nodes in distinguishing between patients with a favorable and unfavorable prognosis.

  • Open Access

    Conditional survival analysis and real-time prognosis prediction in stage III T3-T4 colon cancer patients after surgical resection: a SEER database analysis

    by Hao Zeng, Xueyi Xue, Dongbo Chen, Biaohui Zheng, Baofeng Liang, Zhipeng Que, Dongbo Xu, Xiaojie Wang, Shuangming Lin

    Background Conditional survival (CS) takes into consideration the duration of survival post-surgery and can provide valuable additional insights. The aim of this study was to investigate the risk factors associated with reduced one-year postoperative conditional survival in patients diagnosed with stage III T3-T4 colon cancer and real-time prognosis prediction. Furthermore, we aim to develop pertinent nomograms and predictive models. Methods Clinical data and survival outcomes of patients diagnosed with stage III T3-T4 colon cancer were obtained from the Surveillance, Epidemiology, and End Results (SEER) database, covering the period from 2010 to 2019. Patients were divided into training and validation cohorts at a ratio of 7:3. The training set consisted of a total of 11,386 patients for conditional overall survival (cOS) and 11,800 patients for conditional cancer-specific survival (cCSS), while the validation set comprised 4,876 patients for cOS and 5,055 patients for cCSS. Univariate and multivariate Cox regression analyses were employed to identify independent risk factors influencing one-year postoperative cOS and cCSS. Subsequently, predictive nomograms for cOS and cCSS at 2-year, 3-year, 4-year, and 5-year intervals were constructed based on the identified prognostic factors. The performance of these nomograms was rigorously assessed through metrics including the concordance index (C-index), calibration curves, and the area under the curve (AUC) derived from the receiver operating characteristic (ROC) analysis. Clinical utility was further evaluated using decision curve analysis (DCA). Results A total of 18,190 patients diagnosed with stage III T3-T4 colon cancer were included in this study. Independent risk factors for one-year postoperative cOS and cCSS included age, pT stage, pN stage, pretreatment carcinoembryonic antigen (CEA) levels, receipt of chemotherapy, perineural invasion (PNI), presence of tumor deposits, the number of harvested lymph nodes, and marital status. Gender and tumor site were significantly associated with one-year postoperative cOS, while radiation therapy was notably associated with one-year postoperative cCSS. In the training cohort, the developed nomogram demonstrated a C-index of 0.701 (95% CI, 0.711–0.691) for predicting one-year postoperative cOS and 0.701 (95% CI, 0.713–0.689) for one-year postoperative cCSS. Following validation, the C-index remained robust at 0.707 (95% CI, 0.721–0.693) for one-year postoperative cOS and 0.700 (95% CI, 0.716–0.684) for one-year postoperative cCSS. Receiver operating characteristic (ROC) and calibration curves provided evidence of the model's stability and reliability. Furthermore, decision curve analysis (DCA) underscored the nomogram's superior clinical utility. Conclusions Our developed nomogram serves as a precise and a colon cancer essible tool for clinicians to predict the one-year risk of cOS and cCSS in stage III T3-T4 colon cancer patients who have undergone surgery. These findings empower clinicians in formulating informed clinical decisions and effective follow-up strategies.